Artelo Biosciences, Inc.
PublicArtelo Biosciences, Inc. is now publicly traded
The data on this page reflects Artelo Biosciences, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Seed Round
Mar 27, 2026
Total Funding Raised
$665,300
Company Overview
Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics targeting lipid-signaling pathways to treat cancer, pain, and other conditions.
AI Layer
Non-AI
Keywords
cancer-related anorexiacannabinoid receptor agonistclinical-stage biotechendocannabinoid systempharma cannabisdrug developmentlipid-signaling pathwayspharma licensingFABP5 inhibitorcancer anorexia-cachexia syndromeCACSneuropathic paincancer wastingchemotherapy-induced peripheral neuropathyCIPNCBD cocrystalcrypto on balance sheetSolana
Artelo Biosciences, Inc. Comparables
Compare Artelo Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tensegrity Pharma, Inc. | 63% | |
| Receptor Life Sciences | 57% | |
| 上海赛默罗生物科技有限公司 | 56% |
Artelo Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 27, 2026 | ||||
| Seed Round | Mar 27, 2026 | ||||
| Seed Round | Mar 27, 2026 |
Artelo Biosciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFirmographic Details
Headquarters—
Employee Range16
Year Founded2011
Last FundingMar 27, 2026
See something wrong or outdated?